present
studi
develop
oral
nasal
dna
vaccin
carri
gene
n
gene
ibv
deliv
attenu
salmonella
enterica
serovar
typhimurium
strain
slpvn
respect
safeti
stabil
recombin
salmonella
vaccin
evalu
follow
oral
nasal
administr
chicken
serum
mucos
sampl
collect
antibodi
ibv
measur
chicken
challeng
ibv
strain
nasalocular
rout
week
boost
result
show
oral
nasal
immun
coadminist
slpvn
elicit
signific
ibvspecif
humor
mucos
immun
respons
confer
protect
efficaci
ibv
challeng
higher
chicken
immun
current
studi
show
novel
dna
vaccin
deliv
attenu
typhimurium
may
promis
candid
prevent
infecti
bronchiti
ib
vaccin
efficaci
easili
produc
econom
abl
deliv
oral
nasal
rather
inject
coadministr
slpvn
may
repres
effect
mucos
vaccin
regimen
infecti
bronchiti
ib
acut
highli
contagi
respiratori
infecti
diseas
chicken
worldwid
distribut
continu
major
health
problem
poultri
industri
chicken
age
may
infect
viru
replic
occur
multipl
tissu
ib
caus
mortal
young
chicken
produc
sever
econom
loss
due
poor
weight
gain
reduct
egg
qualiti
quantiti
ib
caus
infecti
bronchiti
viru
ibv
member
coronavirida
famili
unseg
singlestrand
positivesens
rna
genom
kb
length
genom
encod
four
major
structur
protein
surfac
spike
glycoprotein
consist
subunit
membran
glycoprotein
phosphoryl
nucleocapsid
n
protein
envelop
e
protein
glycoprotein
n
protein
elicit
protect
immun
respons
chicken
glycoprotein
report
attach
host
cell
membran
induc
neutral
hemagglutinationinhibit
antibodi
n
protein
abund
virusderiv
protein
produc
throughout
infect
conserv
across
variou
ibv
strain
protein
also
highli
immunogen
carri
epitop
induc
crossreact
antibodi
furthermor
n
protein
may
act
relev
target
immun
recognit
mice
chicken
date
vaccin
effect
mean
prevent
control
ib
poultri
industri
howev
tradit
live
inactiv
viru
vaccin
provid
effect
longterm
control
ib
outbreak
associ
poultri
loss
increas
number
new
serotyp
variant
also
observ
may
attribut
widespread
use
live
attenu
vaccin
potenti
recombin
ibv
strain
problem
associ
tradit
vaccin
spur
major
effort
develop
new
candid
vaccin
safe
effect
control
diseas
sinc
first
avian
dna
vaccin
avian
influenza
viru
shown
efficaci
chicken
dna
vaccin
becom
potenti
candid
protect
varieti
differ
viral
bacteri
parasit
infect
studi
show
vaccin
ibv
dna
vaccin
abl
induc
protect
immun
respons
case
compar
tradit
vaccin
dna
vaccin
avian
speci
offer
mani
advantag
dna
vaccin
may
use
immun
avian
chick
overcom
limit
immatur
immun
system
produc
minim
interfer
passiv
matern
antibodi
dna
vaccin
requir
inject
nake
dna
suitabl
vaccin
larg
number
commerci
chicken
overcom
limit
attenu
salmonella
enterica
serovar
typhimurium
strain
use
dna
vaccin
deliveri
system
multipl
studi
wherebi
recombin
antigen
pathogen
deliv
oral
nasal
induc
strong
humor
cellular
immun
respons
aim
present
studi
develop
dna
vaccin
carri
n
gene
ibv
deliv
attenu
typhimurium
strain
sl
pvn
immun
respons
protect
efficaci
oral
nasal
immun
coadministr
slpvn
also
evalu
provid
inform
dna
vaccin
ibv
chicken
viru
strain
vaccin
attenu
salmonella
strain
ibv
strain
purchas
china
institut
veterinari
drug
control
ivdc
beij
china
propag
allanto
caviti
specificpathogenfre
spf
embryon
chicken
egg
allanto
fluid
harvest
h
postinocul
ib
attenu
live
vaccin
strain
purchas
qianyuanhao
biolog
co
ltd
cell
purchas
shanghai
institut
biolog
scienc
ca
cultur
dulbecco
modifi
eagl
medium
gibco
supplement
fetal
bovin
serum
uml
penicillin
gml
streptomycin
ph
carbon
dioxid
construct
vitro
express
dna
vaccin
plasmid
specif
primer
design
amplifi
gene
n
gene
ibv
strain
bamhi
xhoi
site
ad
end
primer
respect
n
gene
first
amplifi
viru
genom
rna
use
revers
transcriptionpcr
rtpcr
ta
clone
vector
takara
gene
isol
respect
recombin
plasmid
bamhi
xhoi
digest
subclon
site
eukaryot
express
vector
form
construct
verifi
doubleenzym
digest
sequenc
sixwel
tissu
cultur
plate
seed
cell
monolay
confluent
cell
transient
transfect
plasmid
control
use
lipofectamin
kit
invitrogen
life
technolog
ca
accord
manufactur
instruct
h
posttransfect
express
recombin
plasmid
cell
detect
use
indirect
immunofluoresc
assay
primari
antibodi
use
antiserum
chicken
ibv
secondari
antibodi
fluorescein
isothiocyanateconjug
rabbit
antichicken
igg
sigma
transform
gene
n
gene
attenu
typhimurium
produc
compet
cell
attenu
typhimurium
strain
inocul
lb
broth
agit
reach
optic
densiti
nm
od
bacteria
incub
icecold
water
bath
min
bacteria
centrifug
pellet
wash
resuspend
icecold
ultrapur
h
purifi
recombin
plasmid
control
plasmid
subsequ
transform
separ
attenu
typhimurium
compet
cell
electropor
posit
transform
select
lb
agar
plate
contain
gml
kanamycin
confirm
pcr
restrict
enzym
digest
analysi
attenu
typhimurium
strain
carri
plasmid
design
slpvn
slpv
respect
vitro
stabil
plasmid
typhimurium
stabil
dna
vaccin
plasmid
carri
typhimurium
assess
previous
describ
briefli
recombin
attenu
typhimurium
strain
inocul
lb
agar
without
kanamycin
one
gener
ten
coloni
bacteria
randomli
pick
everi
gener
gener
pcr
restrict
enzym
digest
optimum
cultur
condit
product
determin
shakeflask
cultur
static
cultur
inocul
recombin
attenu
typhimurium
strain
lb
broth
kanamycin
harvest
h
postinocul
stabil
calcul
percentag
bacteria
retain
plasmid
ie
ratio
kanamycinresist
coloni
number
lb
agar
kanamycin
total
coloni
number
lb
agar
without
kanamycin
prepar
safeti
recombin
typhimurium
vaccin
recombin
typhimurium
vaccin
strain
slpvn
slpv
grown
static
lb
kanamycin
od
bacteri
cell
harvest
centrifug
wash
suspend
phosphatebuff
salin
pb
ph
concentr
cfuml
determin
plate
serial
dilut
lb
agar
plate
fourdayold
commerci
broiler
chicken
purchas
wuxi
poultri
farm
jiangsu
provinc
china
verifi
safeti
dna
vaccin
deliv
attenu
typhimurium
chicken
divid
three
group
chicken
per
group
simultan
inocul
oral
nasal
equal
amount
recombin
typhimurium
total
dose
cfu
cfu
cfu
respect
chicken
monitor
daili
week
clinic
sign
includ
demeanor
volum
fluid
food
consum
consist
fece
immun
chicken
divid
five
group
chicken
per
group
fast
h
prior
immun
group
chicken
simultan
inocul
oral
nasal
half
total
dose
per
rout
one
follow
cfu
cfu
slpv
cfu
slpvn
coadminist
strain
pb
control
group
immun
chicken
boost
vaccin
compon
dose
week
later
evalu
antibodi
respons
serum
sampl
collect
wing
vein
week
prime
week
boost
prevaccin
sera
also
collect
control
chicken
sera
centrifug
store
analysi
intestin
mucos
sampl
collect
week
postboost
describ
pan
et
al
briefli
entir
small
intestin
collect
shaken
pb
solut
contain
tween
edta
mgml
phenylmethylsulfonyl
fluorid
mgml
intestin
lavag
solut
centrifug
remov
particul
matter
supernat
store
serum
igg
antibodi
titer
intestin
mucos
iga
antibodi
titer
specif
ibv
determin
indirect
enzymelink
immunosorb
assay
elisa
briefli
plate
coat
l
ibv
gml
bicarbonatecarbon
coat
buffer
ph
overnight
plate
wash
three
time
pb
contain
tween
block
overnight
l
fetal
calf
serum
pb
specif
igg
iga
determin
chicken
serum
dilut
intestin
extract
dilut
use
primari
antibodi
horseradish
peroxidas
hrp
conjug
rabbit
antichicken
igg
iga
sigma
use
secondari
antibodi
specif
igg
iga
titer
determin
triplic
endpointdilut
elisa
challeng
three
week
boost
immun
chicken
group
weigh
challeng
egg
infect
dose
ibv
strain
via
nasalocular
rout
chicken
kill
day
viral
challeng
tracheal
tissu
kidney
subsequ
collect
asept
use
inocul
embryo
isol
challeng
viru
embryo
stunt
dead
ibvspecif
lesion
sampl
consid
posit
ibv
neg
embryo
inocul
three
addit
blind
passag
allanto
fluid
chicken
embryo
collect
analyz
use
hemagglutin
ha
statist
analysi
statist
packag
social
scienc
spss
version
spss
inc
chicago
il
use
analyz
differ
group
use
oneway
analysi
varianc
anova
probabl
p
valu
less
consid
signific
p
valu
less
consid
highli
signific
construct
express
dna
vaccin
plasmid
n
gene
success
amplifi
rna
extract
ibv
use
rtpcr
dna
vaccin
plasmid
success
construct
subclon
n
gene
dna
vector
confirm
restrict
enzym
digest
analysi
pcr
sequenc
dna
vaccin
subsequ
transfect
cell
confirm
express
use
indirect
immunofluoresc
assay
cell
transfect
dna
vaccin
display
strong
cytoplasm
fluoresc
reveal
individu
dna
vaccin
encod
n
protein
express
eukaryot
system
fig
cell
transfect
backbon
plasmid
show
fluoresc
typhimurium
pcr
restrict
enzym
digest
analys
show
recombin
plasmid
success
transform
attenu
typhimurium
electropor
plasmid
genet
stabl
recombin
attenu
typhimurium
popul
condit
without
kanamycin
gener
growth
furthermor
optim
cultur
condit
kanamycin
product
observ
plasmid
stabil
maintain
attenu
typhimurium
popul
static
cultur
h
postinocul
plasmid
stabil
shakeflask
cultur
lower
data
shown
result
indic
static
cultur
confer
higher
plasmid
stabil
attenu
typhimurium
safeti
recombin
typhimurium
chicken
abnorm
clinic
sign
observ
test
chicken
receiv
recombin
typhimurium
dose
cfu
cfu
cfu
observ
period
day
first
immun
immun
chicken
weigh
signific
differ
bodi
weight
recombin
typhimuriumimmun
group
group
p
tabl
result
suggest
recombin
typhimurium
neg
effect
bodi
weight
gain
antibodi
respons
analysi
presenc
ibv
antigenspecif
antibodi
sera
intestin
sampl
immun
chicken
determin
elisa
shown
fig
serolog
antibodi
respons
detect
group
receiv
recombin
typhimurium
week
postprim
signific
differ
antibodi
level
recombin
typhimuriumvaccin
group
p
howev
substanti
increas
serum
antibodi
titer
observ
group
coadminist
slpvn
group
week
postboost
signific
differ
observ
group
coadminist
slpvn
group
p
titer
group
significantli
higher
control
group
p
fig
furthermor
intestin
mucos
immun
respons
evid
chicken
immun
recombin
typhimurium
vaccin
group
receiv
highest
mucos
antibodi
titer
titer
group
coadminist
slpvn
higher
group
p
fig
serum
intestin
antibodi
detect
slpv
control
group
immunoprotect
efficaci
assay
evalu
whether
recombin
typhimurium
could
induc
immunoprotect
ibv
group
challeng
ibv
strain
via
nasalocular
rout
week
postboost
mortal
observ
group
protect
respons
level
challeng
analyz
isol
viru
tracheal
kidney
tissu
sampl
percentag
bird
viru
isol
day
group
group
coadminist
sl
slpvn
group
respect
tabl
valu
lower
control
slpv
group
day
challeng
viru
nearli
clear
group
coadminist
fig
protein
n
protein
express
dna
vaccin
cell
cell
transfect
b
backbon
plasmid
c
h
later
protein
express
analyz
use
immunofluoresc
assay
cfu
cfu
slpv
cfu
ml
control
ml
pb
bodi
weight
group
record
day
prime
immun
bodi
weight
group
present
mean
standard
deviat
signific
differ
bodi
weight
detect
group
p
determin
serolog
antibodi
respons
differ
immun
group
group
five
chicken
inocul
oral
nasal
slpvn
slpv
ib
attenu
live
vaccin
pb
serum
sampl
collect
week
primari
vaccin
week
postboost
vaccin
antiibv
igg
antibodi
titer
determin
elisa
data
repres
sampl
mean
n
standard
deviat
signific
differ
p
p
respect
vol
protect
immun
respons
dna
vaccin
slpvn
group
partli
clear
group
result
indic
chicken
immun
coadminist
slpvn
increas
level
resist
ibv
similar
observ
chicken
immun
vaccin
dna
vaccin
also
known
thirdgener
vaccin
promis
approach
effect
control
mani
diseas
field
veterinari
medicin
food
anim
product
recent
sever
studi
shown
dna
vaccin
elicit
protect
immun
respons
ibv
intramuscular
rout
inject
common
rout
dna
vaccin
avian
speci
howev
cost
constraint
involv
livestock
product
need
mass
immun
limit
applic
dna
vaccin
commerci
poultri
industri
limit
may
overcom
use
attenu
salmonella
carrier
dna
vaccin
report
attenu
salmonella
use
extens
deliv
oral
nasal
target
antigen
mucos
system
immun
system
salmonellabas
vaccin
stabl
conveni
rel
inexpens
produc
current
salmonellabas
dna
vaccin
use
express
foreign
antigen
anim
induc
protect
efficaci
varieti
pathogen
especi
invad
via
respiratori
genit
tract
therefor
construct
recombin
salmonella
vaccin
strain
ibv
evalu
immun
efficaci
studi
evalu
humor
mucos
immun
respons
elicit
vaccin
anim
indic
dna
vaccin
use
recombin
attenu
typhimurium
induc
higher
ibvspecif
serum
intestin
mucos
antibodi
titer
vaccin
group
negativecontrol
group
furthermor
coadministr
slpvn
induc
serum
mucos
antibodi
titer
higher
induc
alon
antibodi
respons
especi
mucos
immun
respons
might
play
critic
role
elimin
viru
infect
howev
report
ibv
dna
vaccin
deliv
attenu
salmonella
dose
durat
time
vaccin
need
evalu
enhanc
immun
efficaci
sever
studi
shown
combin
multipl
dna
vaccin
intramuscular
inject
gener
greater
level
protect
singl
dna
vaccin
studi
found
oral
immun
induc
partial
protect
ibv
chicken
day
postchalleng
similar
obtain
use
subcutan
sc
vaccin
recombin
fowlpox
viru
express
lower
percentag
challeng
viru
isol
group
coadminist
sl
slpvn
group
group
control
slpv
group
erad
challeng
viru
group
coadminist
slpvn
earlier
group
day
challeng
viru
almost
fulli
clear
group
coadminist
slpvn
group
partli
clear
group
protect
level
obtain
oral
vaccin
studi
similar
valu
obtain
vaccin
administr
parenter
rout
result
suggest
oral
immun
coadminist
dna
vaccin
encod
ibv
protect
antigen
deliv
attenu
typhimurium
success
strategi
induc
signific
protect
ibv
attenu
salmonella
cell
low
pathogen
high
invas
capac
demonstr
transfer
dna
vaccin
phagocyt
cell
macrophag
dendrit
cell
mechan
gener
imagin
process
includ
follow
salmonella
cell
first
enter
host
via
cell
intestin
taken
dome
area
phagocyt
possibl
migrat
spleen
lymph
chicken
challeng
ibv
strain
nasal
ocularli
week
postboost
challeng
viru
isol
trachea
kidney
immunoprotect
efficaci
assay
protect
respons
level
challeng
analyz
isol
viru
tracheal
kidney
tissu
sampl
percentag
isol
viru
determin
number
posit
chickensth
total
number
chicken
b
percent
protect
determin
number
unaffect
chickensth
total
number
chicken
c
fisher
exact
test
p
fig
determin
intestin
mucos
antibodi
respons
differ
immun
group
group
five
chicken
inocul
oral
nasal
slpvn
sl
pv
ib
attenu
live
vaccin
pb
intestin
sampl
prepar
week
postboost
vaccin
intestin
extract
dilut
use
primari
antibodi
hrpconjug
rabbit
antichicken
iga
sigma
antibodi
use
secondari
antibodi
antiibv
iga
antibodi
titer
intestin
wash
determin
elisa
data
repres
sampl
mean
n
node
activ
subsequ
bacteria
replic
die
due
metabol
attenu
liber
dna
vaccin
nucleu
host
cell
kind
secret
mechan
final
encod
antigen
transcrib
express
order
optim
vaccin
system
futur
necessari
understand
mechan
salmonellamedi
mucos
dna
vaccin
may
influenc
strength
type
immun
respons
induc
summari
studi
demonstr
coadministr
recombin
typhimurium
slpvn
induc
strong
mucos
humor
immun
respons
confer
partial
protect
efficaci
ibv
challeng
chicken
studi
contribut
develop
oral
nasal
deliv
dna
vaccin
may
practic
control
ibv
infect
futur
studi
assess
protect
efficaci
coadminist
recombin
typhimurium
slpvn
heterolog
viru
strain
effect
combin
recombin
typhimurium
tradit
vaccin
ibv
